Tumor-infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast: Correspondence

被引:0
|
作者
Daungsupawong, Hinpetch [1 ]
Wiwanitkit, Viroj [2 ]
机构
[1] Private Acad Consultant, Phonhong, Laos
[2] Saveetha Univ, Saveetha Med Coll & Hosp, Saveetha Inst Med & Tech Sci, Chennai, India
关键词
D O I
10.1007/s10549-024-07489-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:691 / 692
页数:2
相关论文
共 50 条
  • [1] Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
    Toss, Michael S.
    Miligy, I.
    Al-Kawaz, Abdubaqi
    Alsleem, Mansour
    Khout, Hazem
    Rida, Padmashree C.
    Aneja, Ritu
    Green, Andrew R.
    Ellis, Ian O.
    Rakha, Emad A.
    MODERN PATHOLOGY, 2018, 31 (08) : 1226 - 1236
  • [2] Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast
    Pasetto, Camila Vitola
    Aguiar, Fernando Nalesso
    Peixoto, Marcella Bassan
    Doria, Maira Teixeira
    Mota, Bruna Salani
    Maesaka, Jonathan Yugo
    Filassi, Jose Roberto
    Baracat, Edmund Chada
    Goncalves, Rodrigo
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 9 - 18
  • [3] Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
    Agahozo, Marie Colombe
    Hammerl, Dora
    Debets, Reno
    Kok, Marleen
    van Deurzen, Carolien H. M.
    MODERN PATHOLOGY, 2018, 31 (07) : 1012 - 1025
  • [4] Evaluation of Tumor Infiltrating Lymphocytes as a predictive biomarker of recurrence in patients with Ductal Carcinoma In Situ of the breast
    Pasetto, Camila
    Aguiar, Fernando
    Peixoto, Marcella
    Doria, Maira
    Mota, Bruna
    Maesaka, Jonathan
    Filassi, Jose Roberto
    Baracat, Edmund
    Goncalves, Rodrigo
    CANCER RESEARCH, 2024, 84 (09)
  • [5] The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
    Pruneri, G.
    Lazzeroni, M.
    Bagnardi, V.
    Tiburzio, G. B.
    Rotmensz, N.
    DeCensi, A.
    Guerrieri-Gonzaga, A.
    Vingiani, A.
    Curigliano, G.
    Zurrida, S.
    Bassi, F.
    Salgado, R.
    Van den Eynden, G.
    Loi, S.
    Denkert, C.
    Bonanni, B.
    Viale, G.
    ANNALS OF ONCOLOGY, 2017, 28 (02) : 321 - 328
  • [6] Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ
    Xu, Fei-Fei
    Zheng, Sai-Fang
    Xu, Cheng
    Cai, Gang
    Wang, Shu-Bei
    Qi, Wei-Xiang
    Wang, Chao-Fu
    Chen, Jia-Yi
    Lu, Cao
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [7] Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS)
    Farbod Darvishian
    Ugur Ozerdem
    Sylvia Adams
    Jennifer Chun
    Elizabeth Pirraglia
    Elianna Kaplowitz
    Amber Guth
    Deborah Axelrod
    Richard Shapiro
    Alison Price
    Andrea Troxel
    Freya Schnabel
    Daniel Roses
    Annals of Surgical Oncology, 2019, 26 : 3337 - 3343
  • [8] Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS)
    Darvishian, Farbod
    Ozerdem, Ugur
    Adams, Sylvia
    Chun, Jennifer
    Pirraglia, Elizabeth
    Kaplowitz, Elianna
    Guth, Amber
    Axelrod, Deborah
    Shapiro, Richard
    Price, Alison
    Troxel, Andrea
    Schnabel, Freya
    Roses, Daniel
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3337 - 3343
  • [9] Analysis of tumor-infiltrating lymphocytes (TILs) reveals biologically different subgroups of breast ductal carcinoma in situ
    Beguinot-Cornillon, Marie
    Dauplat, Marie -Melanie
    Kwiatkowski, Fabrice
    Lebouedec, Guillaume
    Tixier, Lucie
    Pomel, Christophe
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    CANCER RESEARCH, 2016, 76
  • [10] Tumor-infiltrating lymphocytes in breast ductal carcinoma in situ: Correlations with tumor pathobiology in a French cohort of 495 cases (BONBIS)
    Bayol, Beryl
    Tixier-Deves, Lucie
    Dauplat, Marie
    Kwiatkowski, Fabrice
    Cayre, Anne
    Abrial, Catherine
    Azria, David
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    CANCER RESEARCH, 2018, 78 (04)